High cumulative dose exposure to voriconazole is associated with cutaneous squamous cell carcinoma in lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 31, Issue 7, 2012, Pages 694-699

  Singer, Jonathan P ^a   Boker, Andreas ^a   Metchnikoff, Christopher ^a   Binstock, Maxwell ^a   Boettger, Rebecca ^a   Golden, Jeffrey A ^a   Glidden, David V ^b   Arron, Sarah T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

lung transplantation; risk factors; skin cancer; squamous cell carcinoma; voriconazole

Indexed keywords

VORICONAZOLE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; GRAFT RECIPIENT; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PHOTOTOXICITY; PRIORITY JOURNAL; SKIN CARCINOMA; SURVIVAL;

ADULT; ANTIFUNGAL AGENTS; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSION; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; PYRIMIDINES; RETROSPECTIVE STUDIES; RISK FACTORS; SKIN NEOPLASMS; TRIAZOLES;

EID: 84861908311     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.02.033     Document Type: Article

References (32)

1. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: Advances in therapy and management: part 1. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011;65:253-61.
2. Georgopapadakou NH. Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitors. Expert Opin Investig Drugs 2001;10:269-80. (Pubitemid 32117936)
3. Hilliard T, Edwards S, Buchdahl R, et al. Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros 2005;4:215-20. (Pubitemid 43013027)
4. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003;36:630-7. (Pubitemid 36259570)
5. Walsh TJ, Lutsar I, Driscoll T, et al. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. Pediatr Infect Dis J 2002;21:240-8. (Pubitemid 34214142)
6. Voriconazole [package insert]. New York: Pfizer; 2009.
7. Denning DW, Griffiths CE. Muco-cutaneous retinoid-effects and facial erythema related to the novel triazole antifungal agent voriconazole. Clin Exp Dermatol 2001;26:648-53. (Pubitemid 33070418)
8. Dolan CK, Hall MA, Blazes DL, Norwood CW. Pseudoporphyria as a result of voriconazole use: a case report. Int J Dermatol 2004;43:768-71. (Pubitemid 39405866)
9. Frick MA, Soler-Palacin P, Martin Nalda A, Guarner ME, Nadal CF. Photosensitivity in immunocompromised patients receiving long-term therapy with oral voriconazole. Pediatr Infect Dis J 2010;29:480-1.
10. Kwong WT, Hsu S. Pseudoporphyria associated with voriconazole. J Drugs Dermatol 2007;6:1042-4.
11. Malani AN, Aronoff DM. Voriconazole-induced photosensitivity. Clin Med Res 2008;6:83-5.
12. Racette AJ, Roenigk HH Jr, Hansen R, Mendelson D, Park A. Photoaging and phototoxicity from long-term voriconazole treatment in a 15-year-old girl. J Am Acad Dermatol 2005;52(5 Suppl 1):S81-5.
13. Rubenstein M, Levy ML, Metry D. Voriconazole-induced retinoid-like photosensitivity in children. Pediatr Dermatol 2004;21:675-8. (Pubitemid 39657395)
14. Tolland JP, McKeown PP, Corbett JR. Voriconazole-induced pseudoporphyria. Photodermatol Photoimmunol Photomed 2007;23:29-31. (Pubitemid 46189304)
15. Brunel AS, Fraisse T, Lechiche C, Pinzani V, Mauboussin JM, Sotto A. Multifocal squamous cell carcinomas in an HIV-infected patient with a long-term voriconazole therapy. aids 2008;22:905-6.
16. Cowen EW, Nguyen JC, Miller DD, et al. Chronic phototoxicity and aggressive squamous cell carcinoma of the skin in children and adults during treatment with voriconazole. J Am Acad Dermatol 2010;62:31-7.
17. McCarthy KL, Playford EG, Looke DF, Whitby M. Severe photosensitivity causing multifocal squamous cell carcinomas secondary to prolonged voriconazole therapy. Clin Infect Dis 2007;44:e55-6.
18. Vanacker A, Fabre G, Van Dorpe J, Peetermans WE, Maes B. Aggressive cutaneous squamous cell carcinoma associated with prolonged voriconazole therapy in a renal transplant patient. Am J Transplant 2008;8:877-80. (Pubitemid 351347751)
19. Miller DD, Cowen EW, Nguyen JC, McCalmont TH, Fox LP. Melanoma associated with long-term voriconazole therapy: a new manifestation of chronic photosensitivity. Arch Dermatol 2010;146:300-4.
20. Frisch S, Askari SK, Beaty SR, Burkemper CN. X-linked chronic granulomatous disease with voriconazole-induced photosensitivity/ photoaging reaction. J Drugs Dermatol 2010;9:562-4.
21. Gomez-Moyano E, Vera-Casano A, Moreno-Perez D, Sanz-Trelles A, Crespo-Erchiga V. Lupus erythematosus-like lesions by voriconazole in an infant with chronic granulomatous disease. Pediatr Dermatol 2010;27:105-6.
22. Epaulard O, Saint-Raymond C, Villier C, et al. Multiple aggressive squamous cell carcinomas associated with prolonged voriconazole therapy in four immunocompromised patients. Clin Microbiol Infect 2010;16:1362-4.
23. Ibrahim SF, Singer JP, Arron ST. Catastrophic squamous cell carcinoma in lung transplant patients treated with voriconazole. Dermatol Surg 2010;36:1752-5.
24. Vadnerkar A, Nguyen MH, Mitsani D, et al. Voriconazole exposure and geographic location are independent risk factors for squamous cell carcinoma of the skin among lung transplant recipients. J Heart Lung Transplant 2010;29:1240-4.
25. Egan TM, Murray S, Bustami RT, et al. Development of the new lung allocation system in the United States. Am J Transplant 2006;6(5 Pt 2):1212-27.
26. Suissa S. Immortal time bias in pharmaco-epidemiology. Am J Epidemiol 2008;167:492-9.
27. Pepe MS, Mori M. Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 1993;12:737-51. (Pubitemid 23134304)
28. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004;91:1229-35. (Pubitemid 39424779)
29. Behrend M, Kolditz M, Kliem V, et al. Malignancies in patients under long-term immunosuppression after kidney transplantation. Transplant Proc 1997;29:834-5. (Pubitemid 27125982)
30. Carroll RP, Ramsay HM, Fryer AA, Hawley CM, Nicol DL, Harden PN. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. Am J Kidney Dis 2003;41:676-83. (Pubitemid 36278387)
31. Fuente MJ, Sabat M, Roca J, Lauzurica R, Fernandez-Figueras MT, Ferrandiz C. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003;149:1221-6. (Pubitemid 38058098)
32. Naldi L, Fortina AB, Lovati S, et al. Risk of nonmelanoma skin cancer in Italian organ transplant recipients. A registry-based study. Transplantation 2000;70:1479-84.